American Healthcare REIT (NYSE:AHR) Raised to “Moderate Buy” at Colliers Securities

American Healthcare REIT (NYSE:AHR) was upgraded by equities researchers at Colliers Securities from a “hold” rating to a “moderate buy” rating in a research report issued to clients and investors on Sunday, Zacks.com reports.

AHR has been the topic of a number of other reports. Bank of America boosted their price target on shares of American Healthcare REIT from $27.00 to $31.00 and gave the company a “buy” rating in a research note on Tuesday, September 24th. JMP Securities boosted their price target on shares of American Healthcare REIT from $18.00 to $30.00 and gave the stock a “market outperform” rating in a report on Friday, September 20th. Truist Financial upped their target price on shares of American Healthcare REIT from $22.00 to $27.00 and gave the company a “buy” rating in a report on Friday, September 20th. Morgan Stanley upped their target price on shares of American Healthcare REIT from $17.00 to $22.00 and gave the company an “overweight” rating in a report on Thursday, August 22nd. Finally, KeyCorp upped their target price on shares of American Healthcare REIT from $16.00 to $27.00 and gave the company an “overweight” rating in a report on Monday, September 16th. One equities research analyst has rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $23.00.

American Healthcare REIT Stock Up 0.5 %

Shares of AHR stock opened at $24.70 on Friday. The company has a quick ratio of 0.29, a current ratio of 0.29 and a debt-to-equity ratio of 0.60. The firm’s 50-day moving average is $22.31 and its two-hundred day moving average is $17.36. American Healthcare REIT has a 12 month low of $12.63 and a 12 month high of $26.77.

American Healthcare REIT (NYSE:AHR) last issued its earnings results on Monday, August 5th. The company reported $0.01 EPS for the quarter, missing analysts’ consensus estimates of $0.29 by ($0.28). American Healthcare REIT had a negative return on equity of 2.20% and a negative net margin of 1.99%. The firm had revenue of $504.60 million for the quarter, compared to analysts’ expectations of $506.55 million. The firm’s revenue was up 7.9% compared to the same quarter last year. Equities research analysts anticipate that American Healthcare REIT will post 1.31 EPS for the current fiscal year.

Hedge Funds Weigh In On American Healthcare REIT

A number of large investors have recently made changes to their positions in the stock. Principal Financial Group Inc. increased its holdings in shares of American Healthcare REIT by 2.6% in the 2nd quarter. Principal Financial Group Inc. now owns 6,158,036 shares of the company’s stock valued at $89,970,000 after purchasing an additional 157,762 shares in the last quarter. Centersquare Investment Management LLC acquired a new stake in American Healthcare REIT in the 1st quarter valued at about $63,269,000. V3 Capital Management L.P. acquired a new stake in American Healthcare REIT in the 1st quarter valued at about $42,337,000. Land & Buildings Investment Management LLC grew its stake in American Healthcare REIT by 19.3% in the 2nd quarter. Land & Buildings Investment Management LLC now owns 1,797,400 shares of the company’s stock valued at $26,260,000 after acquiring an additional 290,740 shares during the last quarter. Finally, Goldentree Asset Management LP acquired a new stake in American Healthcare REIT in the 1st quarter valued at about $22,125,000. Hedge funds and other institutional investors own 16.68% of the company’s stock.

American Healthcare REIT Company Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.